A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinethazone
Esatenolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Esatenolol.
Quinethazone
Gallopamil
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Gallopamil.
Quinethazone
Bucindolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Bucindolol.
Quinethazone
Canrenone
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Canrenone.
Quinethazone
Landiolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Landiolol.
Quinethazone
Vinpocetine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Vinpocetine.
Quinethazone
Mannitol busulfan
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Mannitol busulfan.
Quinethazone
Tetrahydropalmatine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Tetrahydropalmatine.
Quinethazone
Naftopidil
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Naftopidil.
Quinethazone
Carboxyamidotriazole
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Carboxyamidotriazole.
Quinethazone
Anisodamine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Anisodamine.
Quinethazone
Talinolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Talinolol.
Quinethazone
Levobetaxolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Levobetaxolol.
Quinethazone
Certoparin
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Certoparin.
Quinethazone
Parnaparin
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Parnaparin.
Quinethazone
Reviparin
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Reviparin.
Quinethazone
Bemiparin
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Bemiparin.
Quinethazone
Niludipine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Niludipine.
Quinethazone
Niguldipine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Niguldipine.
Quinethazone
Manidipine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Manidipine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3